13 reports

Neisseria meningitidis Infections - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Neisseria meningitidis Infections - Pipeline Review, H2 2020, provides an overview of the Neisseria meningitidis Infections (Infectious Disease) pipeline landscape. Neisseria...

  • Vaccine
  • Meningococcal
  • Infectious Disease
  • Biochemical
  • World
  • China
  • Drug Approval

Invasive Meningococcal Disease - Epidemiology Forecast to 2029 Summary Invasive meningococcal disease (IMD) is a life-threatening condition caused by the bacterium Neisseria meningitidis (N. meningitidis). N. meningitidis is an encapsulated gram-negative bacterium that exists without complication...

  • Meningococcal
  • World
  • Vaccination Coverage
  • Prescription Drug Sales

Meningococcal Vaccines Market Size, Share & Trends Analysis Report By Brand (Menactra, Menveo, Bexsero, Trumenba, Nimenrix), By Type, By Serotype, By Age Group, By Sales Channel, By Region and Segment Forecasts, 2022 - 2030 Meningococcal Vaccines Market Growth & Trends The global meningococcal...

  • Meningococcal
  • Vaccine
  • World
  • APAC
  • European Union
  • Drug Approval
  • Health Expenditure

Meningitis - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Meningitis - Pipeline Review, H1 2020, provides an overview of the Meningitis (Infectious Disease) pipeline landscape. "Meningitis is the inflammation caused by viruses and bacteria...

  • Meningococcal
  • World
  • HIV AIDS Prevalence
  • Diagnostic Imaging Density

Neisseria meningitidis Infections - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Neisseria meningitidis Infections - Pipeline Review, H1 2020, provides an overview of the Neisseria meningitidis Infections (Infectious Disease) pipeline landscape. Neisseria...

  • Vaccine
  • Meningococcal
  • Infectious Disease
  • In Vitro Diagnostic Reagent
  • World
  • China
  • India
  • Drug Approval
  • Infectious Disease Incidence

Meningococcal Vaccine Market by Serogroup (MenACWY, MenB/BC, MenC, MenAC, and MenA), Vaccine Type (Conjugate, Polysaccharide, and Subcapsular), and End User (Pediatric, Adults, and Travelers): Global Opportunity Analysis and Industry Forecast, 2018–2026 The global meningococcal vaccine market was valued at $1,935.5...

  • Vaccine
  • Meningococcal
  • World
  • APAC
  • Health Expenditure

Meningitis - Pipeline Review, H2 2019 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Meningitis - Pipeline Review, H2 2019, provides an overview of the Meningitis (Infectious Disease) pipeline landscape. "Meningitis is the inflammation caused by viruses and bacteria...

  • Meningococcal
  • Infectious Disease
  • Vaccine
  • Biopharmaceutical
  • World
  • HIV AIDS Prevalence
  • HIV AIDS Mortality Rate

Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, Influenza, Hepatitis, Polio, Meningococcal, DTP, Rotavirus, MMR, HPV SUBMARKET: Regional Markets Asia vaccines market is estimated at $7bn in 2018 and is expected to grow at a...

  • Infectious Disease
  • Biotech Vaccine
  • Pharmaceutical
  • Hepatitis
  • Vaccine
  • Influenza
  • Meningococcal
  • Asia

Meningitis (Infectious Disease) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Meningitis – Drugs In Development, 2021, provides an overview of the Meningitis (Infectious Disease) pipeline landscape. Meningitis is the inflammation caused...

  • Meningococcal
  • Drug Development
  • World
  • India
  • HIV AIDS Prevalence
  • HIV AIDS Mortality Rate

The recent inclusion of premium-priced meningococcal B (MenB) vaccines into the routine immunization schedules of the US, Italy, and the UK is set to drive strong market growth, which will be further boosted by the anticipated launch of GlaxoSmithKline’s pentavalent MenABCW-135Y vaccine from 2021. This report addresses the following...

  • Vaccine
  • Meningococcal
  • United States
  • Vaccination Coverage
  • Elderly Population

EpiCast Report: Meningococcal Disease - Epidemiology Forecast to 2025 Summary Invasive meningococcal disease (IMD) is a life-threatening condition caused by the bacterium Neisseria meningitidis (N. meningitidis), an encapsulated gram-negative diplococcus that is a pathogen exclusive to humans. N. meningitidis is carried...

  • Meningococcal
  • Epidemiology
  • United States
  • Brazil
  • Japan
  • Germany
  • Italy
  • Infectious Disease Mortality
  • Health Provider Density

DISEASE OVERVIEW Meningitis is an infection of the meninges, the membranes surrounding the brain and spinal cord. It can be caused by a number of different viral and bacterial pathogens including Haemophilus influenzae b (Hib) and Streptococcus pneumoniae. However, in the US, Neisseria meningitidis is the most...

  • Meningococcal
  • Vaccine
  • World

PharmaPoint: Meningococcal Vaccines - Global Drug Forecast and Market Analysis to 2025 Summary Neisseria meningitidis is a Gram-negative, encapsulated diplococcal bacterium and is the causative agent for invasive meningococcal disease. Although relatively rare around the globe, invasive meningococcal disease is widely...

  • Vaccine
  • Meningococcal
  • United States
  • World
  • Vaccination Coverage
  • Drug Approval